UK markets open in 6 hours 6 minutes

Enanta Pharmaceuticals, Inc. (ENTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.91+0.35 (+2.58%)
At close: 04:00PM EDT
13.91 -0.03 (-0.22%)
After hours: 04:01PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Cash flows from operating activities
Net income
-138,237
-133,816
-121,755
-78,996
-36,168
Depreciation & amortisation
2,502
2,371
2,973
3,334
3,644
Deferred income taxes
-
0
0
345
10,608
Stock-based compensation
29,176
28,216
26,969
20,991
19,575
Change in working capital
20,608
8,024
6,789
-13,688
12,900
Accounts receivable
14,412
11,704
3,258
-84
27,821
Accounts payable
4,709
-1,151
-4,634
3,774
-883
Other working capital
-99,190
-112,212
-86,907
-70,746
5,643
Other non-cash items
-
-5,243
-929
-4,098
-3,775
Net cash provided by operating activities
-92,501
-103,154
-84,782
-69,996
7,088
Cash flows from investing activities
Investments in property, plant and equipment
-6,689
-9,058
-2,125
-750
-1,445
Purchases of investments
-452,861
-373,391
-171,446
-307,348
-338,553
Sales/maturities of investments
359,286
328,871
228,468
345,089
359,828
Net cash used for investing activities
-100,264
-53,578
54,897
36,991
19,830
Cash flows from financing activities
Debt repayment
-
-
-
-
0
Other financing activities
196,560
195,918
-1,229
-534
-1,498
Net cash used provided by (used for) financing activities
190,475
198,126
20,033
3,080
8,983
Net change in cash
-2,290
41,394
-9,852
-29,925
35,901
Cash at beginning of period
46,191
47,962
57,814
87,739
51,838
Cash at end of period
43,901
89,356
47,962
57,814
87,739
Free cash flow
Operating cash flow
-92,501
-103,154
-84,782
-69,996
7,088
Capital expenditure
-6,689
-9,058
-2,125
-750
-1,445
Free cash flow
-99,190
-112,212
-86,907
-70,746
5,643